Capecitabine is an orally administered fluoropyrimidine carbamate that acts as a cytotoxic agent against tumour cells. It is primarily used to treat breast, gastric, and colorectal cancers. As a critical component in oncology care, it is available in several high-quality generic versions. Our pharmacy ensures you can access authentic treatments containing Capecitabine through a secure and professional service.
Capecitabine is a chemotherapy medicine that belongs to the class of oral antimetabolites. It works inside the body to stop cancer cells from growing and spreading. The drug is taken by mouth and is found in several brand-name and generic products sold in the United Kingdom, including Xeloda, Capnat and plain-label capecitabine tablets.
In the UK, capecitabine is available as:
All of these products come in oral tablet form, and they are usually prescribed in cycles that last several weeks, followed by a rest period. The exact strength and schedule depend on the individual medication and the condition being treated, so patients should always follow the information that comes with their specific prescription.
Capecitabine is used primarily for cancers that respond to a drug called 5-fluorouracil (5-FU). In the UK it is approved for:
The medication is usually given to adults whose cancer is not curable with surgery alone, aiming to slow tumour growth, relieve symptoms and improve quality of life. Some clinicians may also prescribe capecitabine for other tumour types based on emerging evidence, but those uses are considered off-label.
Capecitabine is a pro-drug, meaning it is inactive until the body changes it into the active form, 5-FU. This conversion mainly occurs inside cancer cells, where enzymes are more abundant than in normal tissue. Once turned into 5-FU, the drug disrupts the cancer cells’ ability to copy DNA, which stops them from dividing and eventually leads to cell death. Because the activation happens mostly within tumours, capecitabine tends to cause fewer side effects than an intravenous 5-FU injection, although some side effects are still common.
People taking capecitabine often notice mild, temporary effects such as:
These reactions usually lessen when the treatment cycle ends or with simple supportive measures.
Although rare, some reactions require urgent medical attention:
If any of these signs develop, seek help from a healthcare professional without delay.
Capecitabine should be used with care in certain situations:
Patients with these conditions must discuss alternatives with their specialist.
Capecitabine can interact with other substances, so patients should be aware of general categories:
Because each medication containing capecitabine may have its own interaction list, readers should refer to the specific product information for full details.
Store tablets in a dry place below 30 °C and keep them out of reach of children. Treatment often follows a pattern of several weeks on medication followed by a rest period, but the exact schedule varies between Xeloda, Capnat and other generic forms. Always read the patient leaflet that comes with your medication and follow the directions on the label.
For detailed usage, dosing, administration, refer to your specific medication's information.
This article offers general educational information about capecitabine as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing capecitabine may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
